579 related articles for article (PubMed ID: 25585951)
21. Impact of donor and recipient age difference on long-term allograft survival after living donor renal transplantation: analysis of 478 cases.
Kostakis ID; Moris DN; Barlas A; Bokos I; Darema M; Theodoropoulou E; Karaolanis G; Kostakis A; Boletis I; Zavos G
Clin Transplant; 2013; 27(6):838-43. PubMed ID: 23991890
[TBL] [Abstract][Full Text] [Related]
22. Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts.
Loupy A; Vernerey D; Tinel C; Aubert O; Duong van Huyen JP; Rabant M; Verine J; Nochy D; Empana JP; Martinez F; Glotz D; Jouven X; Legendre C; Lefaucheur C
J Am Soc Nephrol; 2015 Jul; 26(7):1721-31. PubMed ID: 25556173
[TBL] [Abstract][Full Text] [Related]
23. Pancreas transplant alone as an independent risk factor for the development of renal failure: a retrospective study.
Scalea JR; Butler CC; Munivenkatappa RB; Nogueira JM; Campos L; Haririan A; Barth RN; Philosophe B; Bartlett ST; Cooper M
Transplantation; 2008 Dec; 86(12):1789-94. PubMed ID: 19104423
[TBL] [Abstract][Full Text] [Related]
24. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
Tsapepas DS; Vasilescu R; Tanriover B; Coppleson Y; Rekhtman Y; Hardy MA; Dube G; Crew RJ; Ratner LE; Cohen DJ; Mohan S
Transplantation; 2014 Mar; 97(6):642-7. PubMed ID: 24637863
[TBL] [Abstract][Full Text] [Related]
25. Acute rejection and late renal transplant failure: risk factors and prognosis.
Pallardó Mateu LM; Sancho Calabuig A; Capdevila Plaza L; Franco Esteve A
Nephrol Dial Transplant; 2004 Jun; 19 Suppl 3():iii38-42. PubMed ID: 15192134
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-2 receptor antibody does not reduce rejection risk in low immunological risk or tacrolimus-treated intermediate immunological risk renal transplant recipients.
Lim WH; Chadban SJ; Campbell S; Dent H; Russ GR; McDonald SP
Nephrology (Carlton); 2010 Apr; 15(3):368-76. PubMed ID: 20470309
[TBL] [Abstract][Full Text] [Related]
27. Projecting long-term graft and patient survival after transplantation.
Levy AR; Briggs AH; Johnston K; MacLean JR; Yuan Y; L'Italien GJ; Kalsekar A; Schnitzler MA
Value Health; 2014 Mar; 17(2):254-60. PubMed ID: 24636384
[TBL] [Abstract][Full Text] [Related]
28. Tacrolimus exposure in the real world: an analysis from the Mycophenolic acid Observational REnal transplant study.
Shihab FS; Olyaei A; Wiland A; McCague K; Norman DJ
Clin Transplant; 2014 Jul; 28(7):768-75. PubMed ID: 24754603
[TBL] [Abstract][Full Text] [Related]
29. Significant decrease in glomerular filtration rate at 5 years posttransplantation in the recipients of live donor kidneys 50 years of age or older.
Jain N; Airy M; Kumari P; Hull D; Ranga KV
Transplant Proc; 2010 Jun; 42(5):1648-53. PubMed ID: 20620493
[TBL] [Abstract][Full Text] [Related]
30. Kidney donor risk index is a good prognostic tool for graft outcomes in deceased donor kidney transplantation with short, cold ischemic time.
Han M; Jeong JC; Koo TY; Jeon HJ; Kwon HY; Kim YJ; Ryu HJ; Ahn C; Yang J
Clin Transplant; 2014 Mar; 28(3):337-44. PubMed ID: 24506770
[TBL] [Abstract][Full Text] [Related]
31. Pancreas transplant outcomes for United States (US) cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR).
Gruessner AC; Sutherland DE
Clin Transpl; 2008; ():45-56. PubMed ID: 19708445
[TBL] [Abstract][Full Text] [Related]
32. First year renal function as a predictor of kidney allograft outcome.
Resende L; Guerra J; Santana A; Mil-Homens C; Abreu F; da Costa AG
Transplant Proc; 2009 Apr; 41(3):846-8. PubMed ID: 19376368
[TBL] [Abstract][Full Text] [Related]
33. Kidney Transplantation From Old Deceased Donors: Impact of Uric Acid Level-A Quarter-Century of Experience in One Transplant Center.
Magott-Procelewska M; Madziarska K; Boratynska M; Chudoba P; Lepiesza A; Mazanowska O; Zmonarski S; Madziarski M; Hap K; Klinger M
Transplant Proc; 2018; 50(6):1701-1704. PubMed ID: 30056885
[TBL] [Abstract][Full Text] [Related]
34. Differential Characteristics of Kidney Transplant Recipients According to 1-Year Chronic Kidney Disease Stage 3a and Stage 3b Graft Function.
Baek CH; Kim H; Yang WS; Han DJ; Park SK
Artif Organs; 2017 Apr; 41(4):381-391. PubMed ID: 27653963
[TBL] [Abstract][Full Text] [Related]
35. Why does kidney allograft fail? A long-term single-center experience.
Alarrayed S; El-Agroudy A; Al-Arrayed A; Ghareeb S; Farid E; Garadah T; Abdulla S
Saudi J Kidney Dis Transpl; 2011 Jul; 22(4):818-24. PubMed ID: 21743242
[TBL] [Abstract][Full Text] [Related]
36. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
[TBL] [Abstract][Full Text] [Related]
37. Factors associated with improvement in deceased donor renal allograft function in the 1990s.
Keith DS; DeMattos A; Golconda M; Prather J; Cantarovich M; Paraskevas S; Tchervenkov J; Norman DJ
J Am Soc Nephrol; 2005 May; 16(5):1512-21. PubMed ID: 15772252
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
39. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
[TBL] [Abstract][Full Text] [Related]
40. Better actual 10-year renal transplant outcomes of 80% reduced cyclosporine exposure with sirolimus base therapy compared with full cyclosporine exposure without or with concomittant sirolimus treatment.
Pliszczynski J; Kahan BD
Transplant Proc; 2011 Dec; 43(10):3657-68. PubMed ID: 22172822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
